Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics

Fig. 1

Scatter dot plots of serum irisin levels in patients with invasive breast cancer and controls. Mean values ± standard deviation are also denoted. Serum irisin levels were significantly lower in breast cancer patients compared to controls (2.47 ± 0.57 and 3.24 ± 0.66 μg/ml, respectively, p < 0.001)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us